Form 4 for GILD Gilead Sciences
Accepted 2024-09-13 00:00:00 ET · period of report 2024-09-12 · accession 0001127602-24-023946 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-13 | 2024-09-12 | GILD | Parsey Merdad | Chief Medical Off | S - Sale+OE | $84.50 | -21.2K | 102.2K | -17% | -$1.80M |
| D | 2024-09-13 | 2024-09-12 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | $57.92 | +25.0K | 123.4K | +25% | +$1.45M |
| D | 2024-09-13 | 2024-09-12 | GILD | Parsey Merdad | Chief Medical Off | M - OptEx | $0.00 | -25.0K | 146.7K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | S | D | 21,246 | $84.50 | 102,189 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-12 | M | A | 25,000 | $57.92 | 123,435 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-09-12 | M | D | 25,000 | $0.00 | 146,670 | D | $57.92 · — to 2032-03-10 | 25,000 Common Stock | (F2) The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |